Dr. Shaf Keshavjee | |
|---|---|
 Keshavjee (right), with Katie Sutherland, who received a double lung transplant | |
| Born | |
| Education | University of Toronto (MD), Harvard University (fellowship in airway surgery), University of London (fellowship in heart-lung transplant) |
| Relatives | Mohamed Keshavjee |
| Medical career | |
| Profession | Thoracic and transplant surgeon |
| Research | Lung injury related to lung transplantation, molecular diagnostics for transplantation, gene therapy in lung transplantation |
Shaf Keshavjee is a Canadian surgeon and the current Surgeon-in-Chief at University Health Network in Toronto, the Director of the Toronto Lung Transplant Program, as well as a clinical scientist and professor with the University of Toronto.[1]
His clinical practice in Thoracic Surgery and Transplant Surgery is based at the Toronto General Hospital, where he also leads a research team in lung transplantation studies. Keshavjee gained international recognition for the development of his lung preservation solution for donor lungs en route to transplantation; this solution is now the standard technique utilized by transplantation programs around the world. Further, he broke new ground with his research to the recondition and repair of injured human donor lungs, making them suitable for patient transplantation, using the Toronto XVIVO Lung Perfusion System. His work has allowed for an increase in the number of available donor lungs.[2]
- ^ "Shaf Keshavjee | UHN Research". www.uhnresearch.ca.
- ^ "Toronto lung transplant surgeon leading innovations to boost donor organ pool". thestar.com. March 11, 2013.